Publications
149
Citations
8,843
Est. group size
~46
Recurring co-author estimate
Active years
24
Publishing since 2003
Jeffrey C. Horowitz studies lung diseases, with a particular focus on pulmonary fibrosis (scarring of lung tissue that impairs breathing) and how factors like cell metabolism, oxygen levels, and specific proteins drive this scarring process. His work also extends to critical care topics such as mechanical ventilation, oxygen therapy, sepsis outcomes, and the impact of COVID-19 on lung disease and hospital care. Note: a few unrelated physics publications on exciton-polaritons appear in this record, likely due to author name overlap rather than this PI's own research.
Publication output has grown substantially over the last decade, rising from just a few papers per year before 2021 to roughly 15-24 per year in 2022-2025.
Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026
- Beyond Slowing Decline: Leveraging Apoptotic Synergy to Reverse Pulmonary Fibrosis
American Journal of Respiratory Cell and Molecular Biology · 2026
- PAI-1 interaction with sortilin-related receptor 1 is required for lung fibrosis
JCI Insight · 2025
- Long-Range Coherent Emission of Propagating Exciton–Polaritons from a Mach–Zehnder Interferometer
ACS Photonics · 2025
- MCT4 Regulates Hypoxia-Mediated Extracellular Lactate Production in IPF Fibroblasts
American Journal of Respiratory and Critical Care Medicine · 2025
- ZEB1 Serves as a Key Regulator of Pro-fibrotic Signaling in Lung Fibrosis by Modulating miR-96-Dependent Regulation of FoxO3a
American Journal of Respiratory and Critical Care Medicine · 2025
- Lactate Promotes Myofibroblast Differentiation Through GPR-81-mediated Suppression of Cyclic AMP Under Hypoxia
American Journal of Respiratory and Critical Care Medicine · 2025
- Optimization of Inspired Oxygen during Mechanical Ventilation (OPTI-OXYGEN): rationale and design of a pragmatic randomised controlled trial
BMJ Open · 2025
- Long Range Coherence of Bloch Surface Wave Exciton-Polaritons
2025
- Influenza, SARS-CoV-2, and Their Impact on Chronic Lung Diseases and Fibrosis
American Journal Of Pathology · 2024
- Effect of SARS-CoV-2 IgG Seroconversion After Convalescent Plasma Transfusion on Hospital Outcomes in COVID-19
CHEST Critical Care · 2024
- PAI-1 Interaction with Sortilin Related Receptor-1 is Required for Lung Fibrosis
bioRxiv (Cold Spring Harbor Laboratory) · 2024
- Characterizing Progressive Pulmonary Fibrosis in a Multi-center Real World Cohort
2024
- Automated Electronic Alerts Reduce Hyperoxemia in Mechanically Ventilated Patients
2024
- Lactate and Epithelial Mesenchymal Transition (EMT)- Mediated Changes in Cellular Properties by Enhanced Stiffness of an Extracellular Matrix
2024
- Preventable Mortality Among Previously Healthy Patients With Sepsis
2024
- bioRxiv (Cold Spring Harbor Laboratory)×8
- American Journal of Respiratory and Critical Care Medicine×7
- American Journal of Respiratory Cell and Molecular Biology×6
- Physiological Reports×3
- Frontiers in Immunology×3
- Jazmín Calyeca
Medicine · The Ohio State University
- Mauricio Rojas
Medicine · The Ohio State University
- Elizabeth A. Mickler
Medicine · Indiana University
- Ana L. Mora
Medicine · The Ohio State University
- Mauricio Rojas
Medicine · The Ohio State University
This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.
Last updated Jul 19, 2026.
Claim or correct this profile